Ajanta Hospital and Research Centre   Report issue

Academic/Hospital Phase 3
Founded: Lucknow India (2002)

Organization Overview

First Clinical Trial
2014
NCT03477422
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Ajanta Hospital & Research Centre, 765, ABC Complex, Kanpur Road, Alambagh, Lucknow-Uttar Pradesh, 226005, India.

Active Ingredients

Drugs in Phase 3 Trials (3)

ceftriaxone (rocephin) (1 trial)

meropenem (merrem) (1 trial)

sulbactam (unasyn) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 3)

Infections (Phase 3)

Pyelonephritis (Phase 3)

Urinary Tract Infections (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 3